209. Will Trump's pharmaceutical tariffs lower prices and secure supply chains?

About this episode

Thomas J. Bollyky discusses the challenges in the US pharmaceutical market and the implications of Trump's tariffs and pricing deal with the UK.

Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).

People in this episode

Host: Chad P. Bown

Guest: Thomas J. Bollyky

Topics covered

• pharmaceutical market
• tariffs
• drug prices
• supply chain security
• US-UK relations

Keywords

• pharmaceutical tariffs
• drug prices
• supply chain
• Trump administration
• US pharmaceutical market

Mentioned in this episode

Organizations: Council on Foreign Relations

Places: United Kingdom, US

More episodes of Trade Talks

• 212. America's semiconductor policy and the AI race with China · April 28, 2026 · 57 min
• 211. How one small American manufacturer is dealing with Trump's tariffs · April 19, 2026 · 34 min
• 210. What is America's problem with the WTO? · April 10, 2026 · 33 min
• 208. It's been one year since Trump's "Liberation Day" tariffs · April 1, 2026 · 22 min
• 207. What happened on Trump's tariff day · April 4, 2025 · 29 min
• 206. Paul Krugman talks trade, industrial policy, and Trump · March 16, 2025 · 42 min